Cargando…

Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye

PURPOSE: To report the development and therapeutic evaluation of a liposomal nanocarrier for sustained release of latanoprost, in the rabbit eye. METHODS: We fabricated latanoprost-loaded egg-phosphatidylcholine (EggPC) liposomes using the film hydration technique. The delivery vehicles were nano-si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Natarajan, Jayaganesh V, Ang, Marcus, Darwitan, Anastasia, Chattopadhyay, Sujay, Wong, Tina T, Venkatraman, Subbu S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260956/ https://www.ncbi.nlm.nih.gov/pubmed/22275828 http://dx.doi.org/10.2147/IJN.S25468

Ejemplares similares

Sustained Release of an Anti-Glaucoma Drug: Demonstration of Efficacy of a Liposomal Formulation in the Rabbit Eye
por: Natarajan, Jayaganesh V., et al.
Publicado: (2011)

Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab
por: Joseph, Rini Rachel, et al.
Publicado: (2017)

Latanoprost in the treatment of glaucoma
por: Alm, Albert
Publicado: (2014)

Influence of Latanoprost on Retinal Microcirculation in Glaucoma
por: Kremmer, S, et al.
Publicado: (2014)

Biocompatibility and Biodegradation Studies of Subconjunctival Implants in Rabbit Eyes
por: Peng, Yan, et al.
Publicado: (2011)

Effects of the Glaucoma Drugs Latanoprost and Brimonidine on Corneal Temperature
por: Konieczka, Katarzyna, et al.
Publicado: (2019)

Severe Cutaneous Reaction to Latanoprost Eye Drops
por: Yip, Ivan Yeu Ming, et al.
Publicado: (2018)

Tear biomarkers in latanoprost and bimatoprost treated eyes
por: Reddy, Shweta, et al.
Publicado: (2018)

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
por: Pacella, Fernanda, et al.
Publicado: (2012)

A Biodegradable, Sustained-Released, Prednisolone Acetate Microfilm Drug Delivery System Effectively Prolongs Corneal Allograft Survival in the Rat Keratoplasty Model
por: Liu, Yu-Chi, et al.
Publicado: (2013)

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France
por: Lazzaro, Carlo, et al.
Publicado: (2022)

Evaluation of a Sustained-Release Prednisolone Acetate Biodegradable Subconjunctival Implant in a Non-Human Primate Model
por: Liu, Yu-Chi, et al.
Publicado: (2017)

Hollow Microcapsules as Periocular Drug Depot for Sustained Release of Anti-VEGF Protein
por: Radhakrishnan, Krishna, et al.
Publicado: (2019)

Sustained Antibiotic-Eluting Intra-Ocular Lenses: A New Approach
por: Tan, Dulcia W. N., et al.
Publicado: (2016)

Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
por: Quaranta, Luciano, et al.
Publicado: (2016)

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
por: Economou, Mario A, et al.
Publicado: (2018)

The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
por: Tokuda, Naoto, et al.
Publicado: (2015)

Release Retardation of Model Protein on Polyelectrolyte-Coated PLGA Nano- and Microparticles
por: Nugraha, Chandra, et al.
Publicado: (2014)

Allergic Contact Dermatitis Caused by Topical Eye Drops Containing Latanoprost
por: Lee, Ji Hye, et al.
Publicado: (2014)

Latanoprost-associated cystoid macular edema in a patient with phakic eyes
por: Lin, Wei-Che, et al.
Publicado: (2022)

Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost
por: Sacchi, Matteo, et al.
Publicado: (2014)

Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
por: Walimbe, Tejaswini, et al.
Publicado: (2016)

The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
por: Misiuk-Hojlo, Marta, et al.
Publicado: (2018)

Evaluation of a Prednisolone Acetate-Loaded Subconjunctival Implant for the Treatment of Recurrent Uveitis in a Rabbit Model
por: Ang, Marcus, et al.
Publicado: (2014)

Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost
por: Imasawa, Mitsuhiro, et al.
Publicado: (2016)

Additive Effect of Brinzolamide on Diurnal Changes in Intraocular Pressure in Latanoprost-treated Eyes
por: Abe, Keitetsu, et al.
Publicado: (2008)

24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
por: Nakamura, Yoshimi, et al.
Publicado: (2009)

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
por: Russo, Andrea, et al.
Publicado: (2008)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost–timolol, bimatoprost/bimatoprost–timolol, and travoprost/travoprost–timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
por: Lafuma, Antoine, et al.
Publicado: (2011)

Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice
por: Dutca, Laura M., et al.
Publicado: (2018)

Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
por: Rommasi, Foad, et al.
Publicado: (2021)

Cost–Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany
por: Lazzaro, Carlo, et al.
Publicado: (2022)

Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
por: Kwon, Song, et al.
Publicado: (2020)

Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428]
por: Zeitz, Oliver, et al.
Publicado: (2005)

A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
por: Wang, Tao, et al.
Publicado: (2022)

Latanoprost Induced Iris Pigment Epithelial and Ciliary Body Cyst Formation in Hypermetropic Eyes
por: Mohite, Abhijit Anand, et al.
Publicado: (2017)

24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients
por: Shi, Yipeng, et al.
Publicado: (2023)

Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
por: Ma, Guang-Long, et al.
Publicado: (2023)

A 1-Year Randomized Study of the Clinical and Confocal Effects of Tafluprost and Latanoprost in Newly Diagnosed Glaucoma Patients
por: Fogagnolo, Paolo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_465ih68cdltek9bf9631buaq4p